In an attempt to examine the effect of prolonged physical activity on
the function of the GH/IGF-1 axis during the aging process in man, we
have evaluated basal and GHRH (GHRH-29: 1 mu g/kg i.v. as a bolus) sti
mulated GH secretion as well as basal plasma IGF-1 levels in a group o
f 25 healthy runners (50-60 years, mean age 55.5 +/- 0.6) and 24 age-m
atched relatively sedentary normal controls (mean age 55.8 +/- 0.7). T
he runners had a minimum distance in kilometers of 26 km/week for at l
east 15 years, and competed in distances ranging from 16 km to the mar
athon. In runners, GHRH induced an increase of GH which was significan
tly higher (p < 0.001) than that observed in the age-matched controls.
Baseline IGF-1 levels were significantly higher (p < 0.001) in traine
d runners (171 +/- 8.4 mu g/l) compared to the controls (91.1 +/- 5.5
mu g/l). These data show that in middle-age prolonged physical activit
y increases the function of the GH/IGF-1 axis. To clarify the possible
mechanisms underlying the GH/IGF-1 secretory pattern in the runners,
the GH responses to both single and combined administration of GHRH an
d arginine (ARG: 30 g infused over 30 min), a GH secretagogue likely a
cting via inhibition of hypothalamic somatostatin release, were invest
igated in 6 runners (mean age 55 +/- 1.9 years) and 6 controls (mean a
ge 55 +/- 0.9 years). ARG clearly increased the GH response to GHRH in
the controls, whereas it was unable to further potentiate the GH-rele
asing effect of GHRH in runners, thus suggesting that the increased GH
responsiveness to GHRH might be due to an exercise-related decrease i
n endogenous hypothalamic somatostatinergic activity.